$AFYA

FERREIRA SANTOS WELDER sold $55K of AFYA

FERREIRA SANTOS WELDER (Controller) sold 4,161 shares of Afya Ltd (AFYA) at $13.30 on 2026-10-05.

Original reporting
SEC EDGAR · FERREIRA SANTOS WELDER
Published Oct 6, 2026, 8:48 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AFYA
Neutral
high confidence
Mentioned
$AFYA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AFYANeutralLow
01

Why it matters

The transaction is a routine insider sell with limited material impact on price, but it provides transparency for shareholders.

02

Market read

A small insider sell that is unlikely to move the stock significantly but adds to the flow of insider activity data.

03

What to watch

The insider's remaining 35,000 shares still represent a sizable stake, suggesting continued confidence despite the modest sale.

Relevance 3/10Novelty 3/10Timing: today

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$AFYANeutralHigh confidence
Context

Officer sold 4,161 shares for $55,341, reducing holdings to 35,000 shares.

Expected impact

potential slight downward pressure as the market prices the insider sell.

Evidence & confidence

A $55k sale by a controller is a primary filing but the amount is small relative to market cap, limiting material impact.

Market effects

Minimal impact on the healthcare services sector; the sale is too small to affect sector sentiment.

No notable regional effect; the filing is specific to Afya.

Low global relevance; only investors tracking Afya may note the transaction.

Counterpoint

The sale could be interpreted as a signal that the insider expects near‑term weakness, presenting a buying opportunity if the market overreacts.

Key entities

  • Afya Ltd

    US‑listed healthcare services provider (ticker AFYA).

  • FERREIRA SANTOS WELDER

    Controller and officer of Afya Ltd who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AFYAHigh

JPMorgan upgrades Afya stock rating on merger synergies

JPMorgan upgraded Afya Ltd. (AFYA) to Overweight, citing merger synergies of R$1.8 billion and a premium higher education company. The price target was lowered to $19.00 from $21.00. Afya reported Q2 2026 revenue growth of 6% and H1 growth of 7%, with net income rising 14% in Q2 and 7% in H1. The company trades at a P/E ratio of 8 and a 23% free cash flow yield.

$AFYAMed

Afya and Yduqs Confirm Merger Talks of Brazil’s Education Giants

Afya and Yduqs, Brazil's largest medical-education network and education group, confirmed early-stage merger talks on 24 August 2026. Yduqs shares rose 12.1% in São Paulo, while Afya's shares in New York increased 0.77%. The companies' second-quarter financials showed contrasting performances, with Afya in a stronger position. No binding agreements or details have been finalized, and both companies emphasized the preliminary nature of the discussions.

$AFYAMedAI 8/10

Afya (AFYA) Q2 2026 Earnings Call Transcript

Afya (AFYA) reported Q2 2026 revenue of BRL 1.985 billion, up 7% YoY. Adjusted EBITDA rose 3% to BRL 918 million, while net income increased 7% to BRL 463 million. The company faces AI competition in clinical decision tools but is integrating AI into its iClinic platform. Management reaffirmed its full-year EBITDA guidance of BRL 1.7-1.8 billion.